Pantocid IT Capsule

Pantocid IT Capsule is a combination of two medicines such as Pantoprazole (40mg) and Itopride (150mg). It is used to treat conditions like gastroesophageal reflux disease (Acid reflux) and peptic ulcer disease.

It works by reducing the amount of acid in the stomach which helps in relief of acid related indigestion & heartburn. This capsule also neutralizes acid & promotes easy passage of gas to reduce stomach discomfort. It should be taken in dose and duration as advice by the doctor. Don't take more than the recommended dose.​

• Gastroesophageal reflux disease (acid reflux)
• Peptic ulcer disease

Pantocid IT Capsule may cause some side effects that vary from one patient to another. Most side effects do not require any medical attention and disappear as your body adjusts to the medicine.
Common side effects include:

• Diarrhea
• Stomach pain
• Headache
• Flatulence
• Dizziness
• Increased saliva production
• Dryness in mouth

Seek medical attention in case of any unusual or severe side effects immediately.

• The dosage and duration of the Pantocid IT Capsule are decided by the doctor based on the severity of the condition and other health factors. Take this tablet on an empty stomach for better results.
• Before starting this medicine, please inform your doctor about your medical history. If you experience any signs and symptoms while eating this medication that are not manageable, do not ignore those symptoms because they may lead to a higher risk.​​
  

• Pantocid IT Capsule is a combination of two medicines such as Pantoprazole (40mg) and Itopride (150mg). In which Itopride known as prokinetic agent works on the upper digestive system to make the stomach and intestines flow more freely, making it easier for food to pass through the stomach.
• Also, Pantoprazole is a proton pump inhibitor (PPI) which help to treat acid-related indigestion and heartburn by lowering the amount of acid production in the stomach.​​
  

• Shivaraja, S. (2010). A newer analytical methods for the estimation of rabeprazole, itopride or other anti-ulcer drugs (Master's thesis, Rajiv Gandhi University of Health Sciences (India)).
• Lakhtakia, S., Singh, A. P., Singla, N., Memon, S. F., & Reddy, D. N. (2024). Efficacy and safety of pantoprazole and itopride in patients with overlap of gastroesophageal reflux disease and dyspepsia: A prospective, open‐label, single‐arm pilot study. JGH Open, 8(2), e12988. https://pubmed.ncbi.nlm.nih.gov/38344252/
• BT, P. K., Mamatha, K. R., Nagesh, N. S., Jayanthi, C. R., & VD, B. K. (2016). A comparative prospective study to assess the clinical efficacy and safety of pantoprazole monotherapy versus pantoprazole and itopride dual therapy in patients with gastroesophageal reflux disease in a tertiary care hospital. International Journal of Basic & Clinical Pharmacology, 5(5), 1953. https://www.ijbcp.com/index.php/ijbcp/article/view/617
• Ramadan, N. K., El-Ragehy, N. A., Ragab, M. T., & El-Zeany, B. A. (2015). Simultaneous determination of a binary mixture of pantoprazole sodium and itopride hydrochloride by four spectrophotometric methods. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy, 137, 463-470. https://pubmed.ncbi.nlm.nih.gov/25238185/
• BT, P. K., Mamatha, K. R., Nagesh, N. S., Jayanthi, C. R., & VD, B. K. (2016). A comparative prospective study to assess the clinical efficacy and safety of pantoprazole monotherapy versus pantoprazole and itopride dual therapy in patients with gastroesophageal reflux disease in a tertiary care hospital. International Journal of Basic & Clinical Pharmacology, 5(5), 1953.